Literature DB >> 6213141

Exercise provocable right ventricular outflow tract tachycardia.

E V Palileo, W W Ashley, S Swiryn, R A Bauernfeind, B Strasberg, A T Petropoulos, K M Rosen.   

Abstract

During the past 5 years, we have seen six patients who met inclusion criteria of exertional palpitations, reproducible treadmill (TM) provocable ventricular tachycardia (VT), and performance of electrophysiologic (EP) studies including isoproterenol (ISO) infusion. There were five males and one female, aged 15 to 55 years (mean +/- SD, 31 +/- 18 years). Three patients were trained athletes, two patients had mitral valve prolapse, three had enlarged right ventricular (RV) volumes (all trained athletes), and two had no evidence of organic heart disease. TM testing in all patients demonstrated reproducible exercise-provocable VT of at least 20 beats' duration. TM VT was characterized by left bundle branch block pattern ORS morphology and rates of 150 to 230 bpm (186 +/- 30 bpm). EP did not reproduce VT in five of six patients while ISO at a dose of 2 to 4 micrograms/min (2.5 +/- 0.8 micrograms/min) reproduced VT in all patients. ISO VT was characterized by QRS morphology identical to TM VT and rates of 165 to 230 bpm (191 +/- 26 bpm). Endocardial mapping of ISO VT revealed earliest activity in RV outflow tract. Serial TM testing revealed suppression of TM VT in all six patients on propranolol therapy. Responses to class I drugs were variable and less successful. In summary, we describe a group of patients with common clinical, ECG, and electrophysiologic features who may share a common pathophysiology of VT. Possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213141     DOI: 10.1016/0002-8703(82)90190-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  9 in total

1.  Electrophysiological characteristics and outcome in patients with idiopathic right ventricular arrhythmia compared with arrhythmogenic right ventricular dysplasia.

Authors:  F Niroomand; C Carbucicchio; C Tondo; S Riva; G Fassini; A Apostolo; N Trevisi; P Della Bella
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

2.  Low energy catheter ablation of right ventricular outflow tract tachycardia.

Authors:  A J Ahsan; D Cunningham; E Rowland
Journal:  Br Heart J       Date:  1991-04

3.  Asymmetry of cardiac [123I] meta-iodobenzyl-guanidine scans in patients with ventricular tachycardia and a "clinically normal" heart.

Authors:  J S Gill; G J Hunter; J Gane; D E Ward; A J Camm
Journal:  Br Heart J       Date:  1993-01

4.  Exercise-induced right ventricular tachycardia and arrhythmogenic right ventricular dysplasia: electrophysiologic and therapeutic considerations.

Authors:  S L Solomon; K D Van Osdol; A Massumi; M Warda; R J Hall
Journal:  Tex Heart Inst J       Date:  1983-12

5.  Clinical symptoms in patients with sustained ventricular tachycardia.

Authors:  F Morady; E N Shen; A Bhandari; A B Schwartz; M M Scheinman
Journal:  West J Med       Date:  1985-03

6.  Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.

Authors:  R J Sung; E C Keung; N X Nguyen; E C Huycke
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

7.  Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality.

Authors:  J S Gill; D Mehta; D E Ward; A J Camm
Journal:  Br Heart J       Date:  1992-10

8.  Accelerated idioventricular rhythm of infundibular origin in patients with a concealed form of arrhythmogenic right ventricular dysplasia.

Authors:  B Martini; A Nava; G Thiene; G F Buja; B Canciani; G Miraglia; R Scognamiglio; G M Boffa; L Daliento
Journal:  Br Heart J       Date:  1988-05

9.  Hemodynamic Changes in the Right Ventricle Induced by Variations of Cardiac Output: A Possible Mechanism for Arrhythmia Occurrence in the Outflow Tract.

Authors:  Utku Gülan; Ardan Muammer Saguner; Deniz Akdis; Alexander Gotschy; Felix C Tanner; Sebastian Kozerke; Robert Manka; Corinna Brunckhorst; Markus Holzner; Firat Duru
Journal:  Sci Rep       Date:  2019-01-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.